Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.74 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.74 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CFTR | P13569 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.55 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.55 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.55 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.55 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.55 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL27467504 | 0.98 | SLC6A3 (0.72) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| Phosphine SCHEMBL11469830 | 0.98 | SLC6A3 (0.72) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| SCHEMBL31318316 | 0.96 | SLC6A3 (0.78) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| SCHEMBL27843639 | 0.96 | SLC6A3 (0.74) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| Boric Acid SCHEMBL28688633 | 0.94 | SLC6A3 (0.68) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| Trimethylammonium SCHEMBL27605080 | 0.94 | SLC6A3 (0.68) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| SCHEMBL5700615 | 0.94 | SLC6A3 (0.72) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| SCHEMBL31109161 | 0.92 | SLC6A3 (0.65) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| SCHEMBL22256434 | 0.92 | SLC6A3 (0.65) | SLC6A3SLC6A4SLC6A2LMNATSHR | |
| SCHEMBL22256425 | 0.92 | SLC6A3 (0.65) | SLC6A3SLC6A4SLC6A2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114436833-B | Preparation method of telmisartan key intermediate 4' -bromomethyl biphenyl-2-carboxylate | 南京红太阳医药研究院有限公司 | 2024-12-24 | — | — | CN | claimed |
| CN-114890856-B | Method for synthesizing 2,2' -biphenyl-1-carboxylic acid derivative | 华南理工大学 | 2023-08-22 | — | — | CN | claimed |
| WO-2023088285-A1 | SMALL MOLECULE INHIBITOR AGAINST NASOPHARYNGEAL CARCINOMA, PREPARATION METHOD FOR COMPOUND AND APPLICATION THEREOF | 深圳湾实验室 | 2023-05-25 | — | — | WO | claimed |
| CN-116135850-A | Preparation method and application of small molecule inhibitor and compound for resisting nasopharyngeal carcinoma | 深圳湾实验室 | 2023-05-19 | — | — | CN | claimed |
| CN-114055791-A | Method for bonding middle frame of mobile terminal and piece to be bonded | 韦尔通(厦门)科技股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-108203623-B | Composition, preparation method thereof and application of composition as tobacco flavor | 青岛新昆仑生物科技有限公司 | 2021-04-27 | — | — | CN | claimed |
| CN-109553704-B | Catalyst component for olefin polymerization, catalyst and application | 中国石油化工股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-109553703-B | Catalyst component for olefin polymerization and preparation method thereof | 中国石油化工股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-109553711-B | Catalyst component for olefin polymerization and catalyst thereof | 中国石油化工股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-109553706-B | Catalyst component for olefin polymerization, catalyst and application | 中国石油化工股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-101712648-B | Synthesis method of azepine anthraquinone | NANJING UNIVERSITY OF TECHNOLOGY | 2011-11-09 | — | — | CN | claimed |
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2010-12-16 | — | — | US | claimed |
| US-7795283-B2 | Oxadiazole derivative as DGAT inhibitors | ASTRAZENECA AB (SE) | 2010-09-14 | — | — | US | claimed |
| EP-1805146-A4 | PROCESS FOR PREPARING TELMISARTAN | REDDYS LAB LTD DR (IN) | 2009-01-14 | — | — | EP | claimed |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | ASTRAZENECA AB (SE) | 2008-04-24 | — | — | US | claimed |
| US-20070287840-A1 | Process for Preparing Telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2007-12-13 | — | — | US | claimed |
| EP-1833806-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | claimed |
| EP-1805146-A2 | PROCESS FOR PREPARING TELMISARTAN | Dr. Reddy's Laboratories Ltd. (IN) | 2007-07-11 | — | — | EP | claimed |
| WO-2006064189-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | claimed |
| WO-2006044754-A2 | PROCESS FOR PREPARING TELMISARTAN | DR. REDDY'S LABORATORIES LTD. (IN) | 2006-04-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | DGAT1, DGAT2, GPR119 | SLC6A3 413/4885SLC6A4 886/4885SLC6A2 775/4885 |
| US-20070287840-A1 | Process for Preparing Telmisartan | AGT, TTR, REN | SLC6A3 3387/4885SLC6A4 1416/4885SLC6A2 2289/4885 |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | DGAT1, DGAT2, GPR119 | SLC6A3 363/4885SLC6A4 844/4885SLC6A2 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.